Ezaki Glico Co., Ltd.

As of June 30, 2026, Ezaki Glico Co., Ltd. carries a market capitalization of 327.70B, placing it among publicly traded companies globally. Its enterprise value stands at 277.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Ezaki Glico Co., Ltd.'s next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Ezaki Glico Co., Ltd. has 61.31M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Ezaki Glico Co., Ltd. maintains a current ratio of 1.82, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Ezaki Glico Co., Ltd.'s stock has gained approximately 0.12% over the past 52 weeks. The 50-day moving average sits at 5,082.84, while the 200-day moving average is 5,462.85.

As of June 30, 2026, Ezaki Glico Co., Ltd. holds 68.09B in cash and equivalents against 17.25B in total debt, resulting in a net debt position of -50.84B. Total book value stands at 270.24B, with working capital of 77.39B providing operational flexibility.

Ezaki Glico Co., Ltd.'s most recent stock split took place on September 26, 2014 with a 2:1 split ratio.